Neptune closes private placement
Neptune Technologies & Bioressources has announced the closing of a $4.5mn private placement of common shares, which is designed to help accelerate its business strategy and boost R&D efforts.
News, Analysis & Insights on Nutrition, Supplements, and Health
Neptune Technologies & Bioressources has announced the closing of a $4.5mn private placement of common shares, which is designed to help accelerate its business strategy and boost R&D efforts.
Despite some controversy in reports of the benefits of folate consumption on cardiovascular disease risk, the evidence is now enough to recommend the vitamin for heart health, British scientists have reported.
Synergy has completed a €5 million production facility investment in order to meet growing demand for a number of value-added ingredients.
The first summary of responses to the EC discussion paper on vitamin and mineral levels was presented in Brussels last week, said to have identified the principle problems ahead of the next stage.
Regular consumption of the antioxidant rich green tea could reduce blood lipid levels and cut the risk of developing heart disease, suggests a small trial from Portugal.
Scientists in Texas are looking into whether or not the whey protein isolate ingredient Immunocal could lessen the symptoms of autism by raising glutathione levels in the brain.
EU stakeholders are moving closer to consensus over the setting of maximum vitamin and mineral levels for the EU, said speakers at Friday's EHPM/ERNA conference in Brussels, which unfolded without major aggravation between participants.